Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Cancer Journal (Sudbury, Mass.)|November 26, 2019
Cost-effectiveness of New Targeted Agents in the Treatment of Chronic Lymphocytic LeukemiaR Andrew Harkins, Sharvil P Patel, Christopher R FlowersExpert Review of Pharmacoeconomics & Outcomes Research|October 19, 2019
Cost burden of diffuse large B-cell lymphomaR Andrew Harkins, Sharvil P Patel, Christopher R FlowersClinical Lymphoma, Myeloma & Leukemia|February 18, 2020
Using Informatics Tools to Identify Opportunities for Precision Medicine in Diffuse Large B-cell LymphomaSharvil P Patel, R Andrew Harkins, Michelle J Lee, et al.Current Oncology Reports|May 10, 2023
Important Considerations in the Diagnosis and Management of Post-transplant Lymphoproliferative DisorderMichelle Lee, Aseala Abousaud, R Andrew Harkins, et al.Expert Review of Hematology|September 13, 2019
Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphomaR Andrew Harkins, Andres Chang, Sharvil P Patel, et al.Cancer|May 30, 2020
Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphomaMichelle J Lee, Jean L Koff, Jeffrey M Switchenko, et al.Blood Advances|January 31, 2022
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method surveyR Andrew Harkins, Sharvil P Patel, Michelle J Lee, et al.Cancer Cell|September 8, 2025
Large B cell lymphoma microenvironment archetype profilesXubin Li, Kartik Singhal, Qing Deng, et al.Pageof 1